Novozymes A/S (OTCMKTS:NVZMY) Releases Quarterly Earnings Results

Novozymes A/S (OTCMKTS:NVZMY) issued its earnings results on Thursday. The biotechnology company reported $0.48 earnings per share (EPS) for the quarter, Zacks reports.

Novozymes A/S Stock Up 7.6%

OTCMKTS:NVZMY traded up $4.54 on Thursday, hitting $64.00. The stock had a trading volume of 39,440 shares, compared to its average volume of 37,933. The business’s fifty day moving average is $62.10 and its 200 day moving average is $66.28. The company has a market cap of $29.97 billion, a PE ratio of 37.65, a P/E/G ratio of 1.15 and a beta of 0.96. The company has a quick ratio of 1.07, a current ratio of 1.75 and a debt-to-equity ratio of 0.28. Novozymes A/S has a 52 week low of $53.95 and a 52 week high of $75.99.

Novozymes A/S Cuts Dividend

The company also recently declared a dividend, which was paid on Thursday, September 11th. Shareholders of record on Wednesday, September 3rd were issued a $0.1856 dividend. The ex-dividend date was Tuesday, September 2nd. This represents a yield of 88.0%. Novozymes A/S’s dividend payout ratio is presently 21.76%.

Wall Street Analyst Weigh In

Separately, Zacks Research downgraded Novozymes A/S from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 25th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Novozymes A/S presently has an average rating of “Buy”.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.